β<sub>2</sub>-Adrenergic receptor agonists: a new treatment for diabetic kidney disease?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

β₂-Adrenergic receptor agonists: a new treatment for diabetic kidney disease?

Published:2024-01-01 Issue:1 Volume:326 Page:F1-F2
ISSN:1931-857X
Container-title:American Journal of Physiology-Renal Physiology
language:en
Short-container-title:American Journal of Physiology-Renal Physiology

Author:

Liu Zhiwen¹,Dong Zheng²³^ORCID

Affiliation:

1. Department of Nephrology, The Second Xiangya Hospital at Central South University, Hunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, People’s Republic of China

2. Department of Cellular Biology and Anatomy, Medical College of Georgia at Augusta University, Augusta, Georgia, United States

3. Charlie Norwood Veterans Affairs Medical Center, Augusta, Georgia, United States

Funder

HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases

MOST | National Natural Science Foundation of China

U.S. Department of Veterans Affairs

Publisher

American Physiological Society

Subject

Physiology

Link

https://journals.physiology.org/doi/pdf/10.1152/ajprenal.00299.2023

Reference10 articles.

1. Redox regulation in diabetic kidney disease

2. Molecular pathways that drive diabetic kidney disease

3. Treatment of Diabetic Kidney Disease: Current and Future

4. β₂-Adrenergic receptor agonists as a treatment for diabetic kidney disease

5. Mitochondrial biogenesis induced by the β2-adrenergic receptor agonist formoterol accelerates podocyte recovery from glomerular injury

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP